Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate

BACKGROUND: Proton pump inhibitors (PPIs) are often the first drug of choice in the treatment of eosinophilic oesophagitis (EoE), and in Denmark 8 weeks of high‐dose PPI therapy is recommended as first‐line treatment followed by rebiopsying, reflecting international recommendations. AIMS: To assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Frandsen, Line Tegtmeier, Westmark, Signe, Melgaard, Dorte, Krarup, Anne Lund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Neurogastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498393/
https://www.ncbi.nlm.nih.gov/pubmed/34477326
http://dx.doi.org/10.1002/ueg2.12146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498393/
https://www.ncbi.nlm.nih.gov/pubmed/34477326
http://dx.doi.org/10.1002/ueg2.12146

Ejemplares similares